Grupo Financiero Galicia (NASDAQ:GGAL) was downgraded by equities research analysts at JPMorgan Chase & Co. to an “underweight” rating in a research note issued to investors on Wednesday.Grupo Financiero Galicia S.A. (ADR) (NASDAQ:GGAL) net profit margin is 15.90% and weekly performance is 19.31%. On last trading day company shares ended up $15.14. Analysts mean target price for the company is $12.17. Grupo Financiero Galicia S.A. (ADR) (NASDAQ:GGAL) distance from 50-day simple moving average is 13.53%.
Neonode Inc. (NASDAQ:NEON) announced it will host a conference call to update investors on the status of the business and to comment on the recent rumors and speculations about Neonode and the touchscreen market. The call will take place on Monday June 23th at 8:30AM ET and will consist of a general company update and we will answer pre-submitted questions. Neonode, Inc (NASDAQ:NEON) shares fell -2.53% in last trading session and ended the day on $3.08. NEON Gross Margin is 57.10% and its return on assets is -130.70%. Neonode, Inc (NASDAQ:NEON) quarterly performance is -51.11%.
Senomyx (NASDAQ:SNMX) VP Donald Karanewsky unloaded 20,000 shares of the company’s stock in a transaction that occurred on Thursday, June 19th. The shares were sold at an average price of $8.86, for a total value of $177,200.00. The sale was disclosed in a legal filing with the SEC.Senomyx Inc. (NASDAQ:SNMX) shares moved down -1.70% in last trading session and was closed at $9.27, while trading in range of $8.92-$9.65.Senomyx Inc. (NASDAQ:SNMX) year to date performance is 83.20%.
Agile Therapeutics, Inc., (NASDAQ: AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced that patent U.S. 8,747,888 (‘888 Patent), was issued by the U.S. Patent and Trademark Office on June 10, 2014. The patent is a continuation of its prior patent US 8,246,978 and is intended to provide additional patent protection covering its contraceptive patch, Twirla™ ethinyl estradiol and levonorgestrel transdermal system.Agile Therapeutics Inc (NASDAQ:AGRX) ended the last trading day at $10.33. Company weekly volatility is calculated as 18.60% and price to cash ratio as 64.01. Agile Therapeutics Inc (NASDAQ:AGRX) showed a positive weekly performance of 52.36%.
ParkerVision, Inc. (NASDAQ:PRKR) said a Florida district court judge has thrown out a $173 million patent-infringement verdict won by the chip maker last year against Qualcomm Inc. ParkerVision, Inc. (NASDAQ:PRKR) weekly performance is -63.29%. On last trading day company shares ended up $1.85. Analysts mean target price for the company is $12.85. ParkerVision, Inc. (NASDAQ:PRKR) distance from 50-day simple moving average is -61.35%.